Walleye Trading’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,000
Closed -$44K 5524
2018
Q3
$44K Buy
+6,000
New +$26.3K ﹤0.01% 4602
2017
Q4
Sell
-11,677
Closed -$46 4739
2017
Q3
$46 Sell
11,677
-52,200
-82% -$240K ﹤0.01% 3819
2017
Q2
$326 Sell
63,877
-43,823
-41% -$246K ﹤0.01% 2745
2017
Q1
$743 Buy
107,700
+4,100
+4% +$32K 0.01% 1902
2016
Q4
$969K Buy
103,600
+99,900
+2,700% +$900K 0.01% 1541
2016
Q3
$36K Buy
3,700
+400
+12% +$5.4K ﹤0.01% 3939
2016
Q2
$47K Sell
3,300
-1,800
-35% -$28.1K ﹤0.01% 4019
2016
Q1
$71K Buy
5,100
+3,800
+292% +$55.7K ﹤0.01% 3625
2015
Q4
$27K Buy
1,300
+600
+86% +$9.26K ﹤0.01% 4260
2015
Q3
$9K Buy
+700
New +$11.6K ﹤0.01% 4434

Other funds holding AGTC

Walleye Trading's AGTC Position: Q4 2018 in Review

Walleye Trading sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2018, closing a stake of 6,000 shares — an estimated $44K sold.

Walleye Trading first reported a position in AGTC in Q3 2015 and held it in 10 quarters. The position peaked at $969K in Q4 2016. 54 funds tracked by Wall St. Rank hold AGTC as of Q4 2018.

  • Walleye Trading reported no remaining Applied Genetic Technologies Corporation position as of Q4 2018 after selling out during the quarter.
  • Walleye Trading sold 6,000 Applied Genetic Technologies Corporation shares in Q4 2018, an estimated $44K.
  • Walleye Trading first reported a position in Applied Genetic Technologies Corporation in Q3 2015 and held it in 10 quarters.
  • Walleye Trading's Applied Genetic Technologies Corporation position peaked at $969K in Q4 2016.
  • 54 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.